Skip to content

Anti-inflammatory Effect of Aerobic Exercise in Individual With Increased Cardiovascular Risk

Anti-inflammatory Effect of Aerobic Exercise in Individual With Increased Cardiovascular Risk

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01903941
Enrollment
68
Registered
2013-07-19
Start date
2006-12-31
Completion date
2008-04-30
Last updated
2013-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation

Keywords

exercise

Brief summary

Aerobic physical activity attenuates systemic inflammatory activity in individuals with cardiovascular risk.

Detailed description

Background: Observational studies suggest that exercise has anti-inflammatory effect, however this idea has not been definitively confirmed by randomized clinical trials. Objective: To test the hypothesis that aerobic exercise attenuates systemic inflammatory activity in individuals with cardiovascular risk. Methods: Randomized controlled trial, which included 68 sedentary individuals, with at least two risk factors for coronary heart disease or established cardiovascular disease. The volunteers were randomized to 3 months of supervised aerobic training or just advice when healthy lifestyles. C-reactive protein (CRP) was measured by the method of high sensitivity before and after 3 months of intervention.

Interventions

BEHAVIORALAerobic Exercise
BEHAVIORALOnly Counseling

Sponsors

Escola Bahiana de Medicina e Saude Publica
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

\- Individuals with are between 40 to 70 years, no regular exercise, and at least two risk factor for cardiovascular disease (diabetes, hypertension, dyslipidemia, smoking) or documented cardiovascular disease.

Exclusion criteria

\- Incapacity to exercise.

Design outcomes

Primary

MeasureTime frame
C-reactive protein3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026